Esperion Therapeutics Inc (ESPR)

Cash & Short-Term Investments

$156.16M

Quarterly · Period ending: · USD

ESPR logo

ESPR Cash & Short-Term Investments

Latest reported$167.85M
ESPR FY Cash & Short-Term Investments ($5.90M → $167.85M)
High-resolution chart · PNG

ESPR cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Esperion Therapeutics Inc Cash & Short-Term Investments — Annual fiscal periods (USD)
Period endingCash & Short-Term Investments (USD)
167,852,000
144,761,000
82,248,000
166,861,000
259,333,000
304,962,000
200,781,000
36,973,000
34,468,000
38,165,000
77,336,000
85,038,000
60,062,484
6,511,521
1,571,084
44,853,000
70,286,000
70,228,000
5,903,932
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.